Catalent is a contract development and manufacturing organization, or CDMO. It operates under four segments: biologics, softgel and oral technologies, oral and specialty delivery, and clinical supply services. Catalent derives its revenues primarily from long-term supply agreements with pharmaceutical customers. The company provides a range of development and manufacturing solutions for drugs, protein-based biologics, cell and gene therapies, and consumer health products
WST
VIVK, TBLD, AUID, BHVN, ZWS, INTZ, AXP, JEF, ELV, DHR
BMY
ALLE
FTV